Barbie is out with its latest addition to its Barbie Fashionistas collection, its first-ever doll with autism. The new doll includes traits, clothing and accessories relevant to individuals with ...
Barbie is launching its first autistic doll in an effort to represent how individuals with autism spectrum disorder experience the world around them, USA TODAY can exclusively reveal. The doll, which ...
Mattel is expanding its push for inclusion with the launch of its first autistic Barbie, developed in partnership with autism advocates to reflect how some people on the spectrum experience the world.
There’s a new kind of Barbie girl in this Barbie world. Mattel just released its first autistic Barbie doll in an effort to represent how those with autism spectrum disorder may experience the world ...
Mattel Inc. is introducing a Barbie with autism Monday as the newest member of its line intended to celebrate diversity, joining a collection that already includes Barbies with Down syndrome, a blind ...
For the first time, a Barbie doll with features designed to account for the ways in which individuals with autism experience the world is hitting the market. Mattel, the maker of the iconic toy, said ...
LONDON & NEW YORK--(BUSINESS WIRE)--This morning Vanda, a global leader of high-frequency positioning data and tactical macro insights and Exante Data Inc, an innovative data analytics and global ...
Vanda is a high-frequency positioning data and tactical macro insights provider Vanda was FPE’s sixth investment from FPE Fund III Exante Data is based in New York FPE portfolio company Vanda has ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of vomiting ...
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares are trending on Wednesday. Check out the current price of VNDA stock here. Shares of the biopharmaceutical company jumped 20.20% to $8.45 in ...
Dec 30 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health regulator, becoming the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results